Ceres Nano Overview

  • Year Founded
  • 2008

Year Founded

  • Status
  • Private

  • Employees
  • 40

Employees

  • Latest Deal Type
  • Grant

  • Latest Deal Amount
  • $1.4M

  • Investors
  • 14

Ceres Nano General Information

Description

Developer of biomarker capture particle technology products designed to deliver innovative products, address critical diagnostic needs and provide better patient outcomes. The company's products capture enriches and preserves biomarkers, enabling health institutions to quickly and accurately detect diseases such as cancer, cardiac and infectious diseases, resulting in improved patient outcomes and reduced health care costs.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Diagnostic Equipment
Other Industries
Biotechnology
Primary Office
  • 9460 Innovation Drive
  • Manassas, VA 20110
  • United States
+1 (800) 000-0000

Ceres Nano Timeline

2020202120222023
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Ceres Nano Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
16. Grant 01-Dec-2022 $1.4M 000.00 Completed Generating Revenue
15. Later Stage VC (Series B) 09-Sep-2022 000 000.00 0000 Completed Generating Revenue
14. Grant 21-Apr-2021 00.00 000.00 Completed Generating Revenue
13. Debt - PPP 09-Apr-2020 000.00 Completed Generating Revenue
12. Grant 31-Jan-2020 00000 000.00 Completed Generating Revenue
11. Grant 03-Jun-2019 00000 000.00 Completed Generating Revenue
10. Grant 00000 000.00 Completed Generating Revenue
9. Later Stage VC 07-Feb-2019 00000 000.00 000.00 Completed Generating Revenue
8. Later Stage VC (Series A) 30-May-2018 $8.5M $11M 0000 Completed Generating Revenue
7. Grant 12-Dec-2017 $50K $2.5M Completed Generating Revenue
To view Ceres Nano’s complete valuation and funding history, request access »

Ceres Nano Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B 0,000,000 00.000000 00 00.00 00.00 00 00.00 0.000
Series A 0,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
Seed 2 80,000 $0.001000 $5 $5 1x $2.32 1.33%
Seed 1 400,000 $0.001000 $2.5 $2.5 1x $2.5 3.07%
To view Ceres Nano’s complete cap table history, request access »

Ceres Nano Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of biomarker capture particle technology products designed to deliver innovative products, address critical di
Diagnostic Equipment
Manassas, VA
40 As of 2023
000.00
0000000000 000.00

0-0000

ipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua
0000000000000
Shilat, Israel
00 As of 0000
0000
000000 - 000 0000

000000

ing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut
0000 000000000
Maastricht, Netherlands
0 As of 0000
000.00
00000 00000 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Ceres Nano Competitors (13)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
P-Cure Venture Capital-Backed Shilat, Israel 00 0000 000000 - 000 0000
0000000 0000000000 Venture Capital-Backed Maastricht, Netherlands 0 000.00 00000 00000 000.00
000000000 00000000 Venture Capital-Backed Rockville, MD 0 000.00 0000000000 0 000.00
0000000000000 Venture Capital-Backed Eagan, MN 00 000.00 000000000 - 000.00
0000000000 Formerly VC-backed Paris, France 000 00000 00000000 00000
You’re viewing 5 of 13 competitors. Get the full list »

Ceres Nano Patents

Ceres Nano Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20200340893-A1 Hydrogel particle-enabled large volume fluid processing device and system Inactive 21-Dec-2018 0000000000
EP-2776150-A1 Absorbent dried biofluid collection substrates Inactive 10-Nov-2011 0000000000
EP-2776150-A4 Absorbent dried biofluid collection substrates Inactive 10-Nov-2011 G01N33/543 0

Ceres Nano Executive Team (3)

Name Title Board Seat Contact Info
Ross Dunlap Co-Founder, Chief Executive Officer & Board Member
Benjamin Lepene Chief Technology Officer & COO/ Director Of Research & Development
Robbie Barbero Ph.D Chief Business Officer
To view Ceres Nano’s complete executive team members history, request access »

Ceres Nano Board Members (8)

Name Representing Role Since
Emanuel Petricoin III Self Board Member 000 0000
Ian Wright Self Board Member 000 0000
Ross Dunlap Ceres Nano Co-Founder, Chief Executive Officer & Board Member 000 0000
Scott Gazelle Ph.D GreyBird Ventures Board Member 000 0000
Tom Miller GreyBird Ventures Chairman 000 0000
You’re viewing 5 of 8 board members. Get the full list »

Ceres Nano Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ceres Nano Investors (14)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Birchaven Group Venture Capital Minority 000 0000 000000 0
Streck Corporation Minority 000 0000 000000 0
National Institutes of Health Government 000 0000 000000 0
Bay Area Lyme Fund Corporation Minority 000 0000 000000 0
GreyBird Ventures Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 14 investors. Get the full list »